Marta Villalba Montaner (@MartaVM90) profile picture

Marta Villalba Montaner

@MartaVM90

Hematóloga. La fe. Valencia

Joined December 2021
  • Tweets76
  • Following195
  • Followers91
Marta Villalba Montaner retweeted
IIS La Fe (@IISLaFe) profile picture
IIS La Fe@IISLaFe24 Jul 2025
🎓 ¡Enhorabuena al Dr. Miguel Mansilla Polo por la defensa de su tesis! 💫 Se trata de una investigación, dirigida por los Dres. Rafael Botella y Jaime Sanz, sobre cáncer cutáneo en receptores de TPH que impulsa el avance en dermatología tras el trasplante.
Image from IIS La Fe (@IISLaFe)
Image from IIS La Fe (@IISLaFe)
Image from IIS La Fe (@IISLaFe)
Image from IIS La Fe (@IISLaFe)
1
1
11
2,556
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe14 Jul 2025
PEDRO IS ON FIRE! The level of insight he’s generating is unreal. What a team!!astctjournal.org/article/S26… @TheEBMT @GETH_info @IISLaFe
2
5
323
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe14 Jul 2025
First results are in the multidisciplinary GVHD team at LA FE @IISLaFe @TheEBMT @GETH_info .astctjournal.org/article/S26…
2
4
251
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe3 Jul 2025
Another one! What an incredible year it’s been! Huge congrats to Juan on the EBMT study collaboration on HSCT in ALL. Now for a well-deserved summer break!@ @IISLaFe @Mohty_EBMT @TheEBMT @GETH_info @HospitalLaFe nature.com/articles/s41409-0…
Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study...

Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study...

Bone Marrow Transplantation - Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT

nature.com
6
15
1,044
Marta Villalba Montaner retweeted
Jose Luis Poveda Andrés (@joseluis_pa) profile picture
Jose Luis Poveda Andrés@joseluis_pa15 Jun 2025
El Hospital La Fe supera los 100 trasplantes de médula ósea - Actualidad Valencia #SomosLaFe actualidadvalencia.com/el-ho…
El Hospital La Fe supera los 100 trasplantes de médula ósea de donante en pacientes adultos

El Hospital La Fe supera los 100 trasplantes de médula ósea de donante en pacientes adultos

El hospital se sitúa a la cabeza de nuestro país en este tipo de intervención, al que se recurre en diversas enfermedades oncohematológicas.

actualidadvalencia.com
2
16
582
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe11 Jun 2025
Another one accepted! The team's on an incredible streak — what a year we're having! Engraftment Syndrome after Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantatio… pubmed.ncbi.nlm.nih.gov/4049… @TheEBMT @GETH_info @IISLaFe @HospitalLaFe
Redefining Engraftment Syndrome After Post-Transplant Cyclophosphamide Allogeneic Hematopoietic...

Redefining Engraftment Syndrome After Post-Transplant Cyclophosphamide Allogeneic Hematopoietic...

Engraftment syndrome (ES) is a non-infectious febrile complication of hematopoietic cell transplantation (HCT), with diagnostic challenges, particularly in the allogeneic setting. The increasing use...

pubmed.ncbi.nlm.nih.gov
2
4
209
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe30 May 2025
Another one! Big congrats to Aitana! Our team's scientific production is unstoppable! Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosp… pubmed.ncbi.nlm.nih.gov/4040… @GETH_info @TheEBMT @IISLaFe @HospitalLaFe
Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Tra...

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Tra...

Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a serious complication following allogeneic hematopoietic cell transplantation (HCT). Although post-transplant cyclophosphamide...

pubmed.ncbi.nlm.nih.gov
2
1
6
1,112
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe29 May 2025
A new manuscript in collaboration with the EBMT. This time about aplastic anemia. What a productive year it's been for the Unit. Donor impact on allo-SCT outcomes with PTCy for SAA: a study of the SAAWP EBMT pubmed.ncbi.nlm.nih.gov/4042… @GETH_info @HospitalLaFe @TheEBMT @IISLaFe
Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the...

Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the...

The use of post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis in severe aplastic anemia (SAA) remains understudied, particularly beyond haploidentical transpla...

pubmed.ncbi.nlm.nih.gov
4
9
546
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe9 May 2025
Congratulations to the team on the new manuscript! We continue to push forward—great work Pedro!! Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide pubmed.ncbi.nlm.nih.gov/4006… @GETH_info @GVAsanitat @IISLaFe @HospitalLaFe @TheEBMT
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide -...

Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide -...

Despite the high incidence of diarrhea in hematopoietic cell transplant (HCT) and the frequent involvement of infections, evidence concerning patients receiving post-transplant cyclophosphamide...

pubmed.ncbi.nlm.nih.gov
2
5
355
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe9 May 2025
Another manuscript! This from our colleague from Chile, who chose to stay with the team not just to learn, but to actively drive impactful research. CRS syndrome: implications for transplant outcomes in haplo and HLA-matched HSCT using PTCy pubmed.ncbi.nlm.nih.gov/4026… @TheEBMT
2
5
227
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe29 Apr 2025
📊 Memoria TPH 2024 publicada ❤️ 101 pacientes alotrasplantados Un año más, seguimos como el centro nacional con mayor actividad en alo-TPH. Gracias a todos los que lo hacéis posible. Enhorabuena, equipo. @GVAsanitat @HospitalLaFe @GETH_info @TheEBMT @IISLaFe @ONT_esp @fcarreras
Image from Unidad TPH La Fe (@TPHLaFe)
1
4
15
584
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy ashpublications.org/blood/ar… Severe (Grade 3+) T-ICAHT is strongly associated with increased transfusion burden and inferior survival following CAR T-cell therapy.
T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Key PointsBased on duration and timing of thrombocytopenia, we introduce T-ICAHT as a novel grading that expands on the existing N-ICAHT system.Severe (gra

ashpublications.org
9
31
1,806
Marta Villalba Montaner retweeted
HospitalLaFe (@HospitalLaFe) profile picture
HospitalLaFe@HospitalLaFe22 Apr 2025
🏥La Fe formaliza la creación de un comité multidisciplinar para el abordaje de la enfermedad de #injerto contra receptor ‼️Es una complicación inmunológica, multiorgánica y potencialmente mortal 🔗organismes.san.gva.es/es/web…
Image from HospitalLaFe (@HospitalLaFe)
6
23
1,740
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe3 Apr 2025
Replying to @TPHLaFe @MartaVM90
Relapse patterns after antiCD19 #CART cell therapy + role of allo #SCT, by @aitana_balag , project in collaboration with Dr Mussetti, from @HematICO_Hosp
Image from Unidad TPH La Fe (@TPHLaFe)
3
1
7
805
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe1 Apr 2025
Replying to @TPHLaFe @MartaVM90
T-ICAHT, a novel grading system for #CART cell therapy, presented by Jaime Sanz
Image from Unidad TPH La Fe (@TPHLaFe)
1
2
6
264
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe1 Apr 2025
Impact of donor undergoing #SCT for high risk #AML, by @MartaVM90
Image from Unidad TPH La Fe (@TPHLaFe)
1
1
4
199
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe1 Apr 2025
Impact of donor in severe aplastic anemia undergoi g allo#SCT with PTCy by Juan Montoro
Image from Unidad TPH La Fe (@TPHLaFe)
1
1
3
164
Marta Villalba Montaner retweeted
Unidad TPH La Fe (@TPHLaFe) profile picture
Unidad TPH La Fe@TPHLaFe31 Mar 2025
This #EBMT25 our group is on fire!! Four oral communications (including Juan Montoro at the Presidential Symposium), two posters. Well done! 👏👏@HospitalLaFe @GETH_info #SCT
Image from Unidad TPH La Fe (@TPHLaFe)
2
7
1
34
1,627
RT @AML_Hub: CONGRESS | #EBMT25 @TheEBMT | PRESENTATION @MartaVM90, @HospitalLaFe, shares findings from a retrospective study evaluating th…
1
8
Marta Villalba Montaner retweeted
AML Hub (@AML_Hub) profile picture
AML Hub
@AML_Hub30 Mar 2025
CONGRESS | #EBMT25 | POSTER Jaime Sanz, University Hospital La Fe, Valencia, Spain shares insights on using alternative donor selection strategies in patients with AML undergoing HSCT with PTCy (N = 4003) to improve survival outcomes. Follow our live feed for more updates: aml-hub.com/medical-informat… #AMLsm #leusm #MedicalCongress @TheEBMT
Image from AML Hub (@AML_Hub)
Image from AML Hub (@AML_Hub)
Image from AML Hub (@AML_Hub)
7
24
83,324
Load more